Community management of severe allergies must be integrated and comprehensive, and must consist of more than just epinephrine.
Hourihane
J O
JO
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D010367:Arachis / Q000009:adverse effects; D003153:Community Health Services; D004531:Eggs / Q000009:adverse effects; D004837:Epinephrine / Q000627:therapeutic use*; D005512:Food Hypersensitivity / Q000209:etiology* / Q000276:immunology / Q000628:therapy*; D006801:Humans; D012572:School Health Services; D012720:Severity of Illness Index; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D000318:Adrenergic beta-Agonists; D004837:Epinephrine